RAMM Pharma Corp.
RAMM
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -80.26% | -112.07% | 57.09% | 57.05% | 60.46% |
| Total Depreciation and Amortization | -15.27% | -10.58% | -20.61% | -17.50% | 4.26% |
| Total Amortization of Deferred Charges | -- | -- | -97.84% | -- | -- |
| Total Other Non-Cash Items | 196.63% | 306.03% | -78.11% | -78.69% | -78.19% |
| Change in Net Operating Assets | 617.70% | 504.38% | -137.31% | 355.78% | -504.68% |
| Cash from Operations | 31.39% | 8.45% | 7.58% | 20.72% | 27.85% |
| Capital Expenditure | 15.08% | 24.18% | -635.90% | -109.09% | -133.33% |
| Sale of Property, Plant, and Equipment | -- | -- | 173.94% | 173.94% | 28.25% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -175.05% | -98.91% | -76.12% | -39.04% | -44.92% |
| Cash from Investing | -200.24% | -136.67% | 110.49% | 115.15% | 112.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.88% | 9.53% | 11.16% | 0.86% | -26.31% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 22.38% | 22.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.00% | 126.23% | 123.00% | 200.00% |
| Cash from Financing | 30.88% | 44.53% | 50.34% | 73.19% | -7.33% |
| Foreign Exchange rate Adjustments | 3,616.67% | -95.33% | 0.00% | -62.32% | -101.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.87% | 8.27% | 25.82% | 42.18% | 36.46% |